Deciphera Pharmaceuticals Inc (DCPH)
14.65
+0.47
(+3.31%)
USD |
NASDAQ |
Apr 26, 16:00
14.66
0.00 (0.00%)
Pre-Market: 20:00
Deciphera Pharmaceuticals Cash from Operations (TTM): -146.70M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -146.70M |
September 30, 2023 | -153.05M |
June 30, 2023 | -144.07M |
March 31, 2023 | -150.96M |
December 31, 2022 | -152.86M |
September 30, 2022 | -184.88M |
June 30, 2022 | -218.05M |
March 31, 2022 | -224.49M |
December 31, 2021 | -240.82M |
September 30, 2021 | -222.78M |
June 30, 2021 | -218.12M |
March 31, 2021 | -227.00M |
December 31, 2020 | -239.68M |
Date | Value |
---|---|
September 30, 2020 | -246.39M |
June 30, 2020 | -220.24M |
March 31, 2020 | -196.66M |
December 31, 2019 | -149.30M |
September 30, 2019 | -120.33M |
June 30, 2019 | -122.07M |
March 31, 2019 | -103.10M |
December 31, 2018 | -86.78M |
September 30, 2018 | -72.67M |
June 30, 2018 | -56.60M |
March 31, 2018 | -45.98M |
December 31, 2017 | -36.70M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-246.39M
Minimum
Sep 2020
-120.33M
Maximum
Sep 2019
-188.34M
Average
-196.66M
Median
Mar 2020
Cash from Operations (TTM) Benchmarks
Dynavax Technologies Corp | 100.56M |
Pfizer Inc | 8.70B |
Esperion Therapeutics Inc | -135.49M |
Alnylam Pharmaceuticals Inc | 104.16M |
Geron Corp | -167.74M |